MedPath

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Registration Number
NCT00003287
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy is more effective in treating patients with recurrent or metastatic colorectal cancer.

PURPOSE: Randomized phase III trial to study the effectiveness of combining fluorouracil, leucovorin, and oxaliplatin in different ways in treating patients with recurrent or metastatic colorectal cancer.

Detailed Description

OBJECTIVES: I. Compare the effects of chronomodulated versus nonchronomodulated infusional administration of a 3 drug high-dose chemotherapy regimen on survival in patients with locoregionally recurrent or metastatic colorectal cancer. II. Assess the antitumor effect of the combination of fluorouracil, leucovorin calcium, and oxaliplatin given as first line chemotherapy in these patients. III. Assess the response rate and toxicity of this treatment in these patients. IV. Assess the quality of life of patients receiving this treatment.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to performance status (ECOG 0-1 vs 2), extent of liver involvement (none vs less than 25% vs 25% or greater), and institution. Patients are randomized into 2 arms: Arm I (chronotherapy): Patients receive a 4 day infusion of fluorouracil, leucovorin calcium, and oxaliplatin administered via pump using chronomodulated delivery rates. Arm II (fixed infusion rate): Patients receive leucovorin calcium and oxaliplatin as 2 hour concurrent infusions followed by fluorouracil as a 22 hour infusion on day 1. On day 2, patients receive a 2 hour infusion of leucovorin calcium followed by a 22 hour infusion of fluorouracil. For patients on both arms, courses repeat every 2 weeks until the occurrence of disease progression, severe toxicity, or complete remission for a minimum of 4 months. Quality of life is assessed prior to treatment and 2 weeks after courses 4 and 8. Patients are followed for survival.

PROJECTED ACCRUAL: A total of 554 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
554
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (36)

University Hospital of Heraklion

🇬🇷

Iraklion (Heraklion), Crete, Greece

Centre Hospitalier de Montlucon

🇫🇷

Montlucon, France

Hopital Notre-Dame de Bon Secours

🇫🇷

Metz, France

Haukeland Hospital - University of Bergen

🇳🇴

Bergen, Norway

Hospital Fernando Fonseca

🇵🇹

Amadora, Portugal

Hospital De Santo Antonio Dos Capuchos

🇵🇹

Lisbon (Lisboa), Portugal

Azienda Ospedaliera "Santa Maria Degli Angeli"

🇮🇹

Pordenone, Italy

Sunnybrook and Women's College Health Sciences Centre

🇨🇦

North York, Ontario, Canada

Centre Jean Perrin

🇫🇷

Clermont-Ferrand, France

Klinikum der Friedrich-Schiller Universitaet Jena

🇩🇪

Jena, Germany

Azienda Ospedale S. Luigi - Universita Di Torino

🇮🇹

Orbassano, (Torino), Italy

Hopital Bellevue

🇫🇷

Saint Etienne, France

Krankenanstalt Rudolfstiftung

🇦🇹

Vienna (Wien), Austria

Clinique Sainte Elisabeth

🇧🇪

Namur, Belgium

Universita G.D'Annunzio Di Chieti

🇮🇹

Chieti, Italy

Istituti Fisioterapici Ospitalieri - Roma

🇮🇹

Rome, Italy

Centre Hospitalier de la Cote Basque

🇫🇷

Bayonne, France

Centre Hospitalier Regional de Rimouski

🇨🇦

Rimouski, Quebec, Canada

Fondazione Salvatore Maugeri

🇮🇹

Pavia, Italy

Ospedale Oncologico Regionale

🇮🇹

RIONERO in VULTURE, Italy

Centre de Lute Contre le Cancer,Georges-Francois Leclerc

🇫🇷

Dijon, France

Hopital Perpetuel Secours

🇫🇷

Levallois-Perret, France

Centre Oscar Lambret

🇫🇷

Lille, France

Centre Hospital Regional Universitaire de Limoges

🇫🇷

Limoges, France

Clinique Hartmann

🇫🇷

Neuilly sur Seine, France

Centre Rene Huguenin

🇫🇷

Saint Cloud, France

Hopital Paul Brousse

🇫🇷

Villejuif, France

Centre Hospitalier Notre Dame - Reine Fabiola

🇧🇪

Charleroi, Belgium

Clinique du Parc

🇫🇷

Croix, France

Hopital Cochin

🇫🇷

Paris, France

Cliniques Universitaires Saint-Luc

🇧🇪

Brussels (Bruxelles), Belgium

Les Cliniques Saint-Joseph ASBL

🇧🇪

Liege (Luik), Belgium

Hopital Saint Jean

🇧🇪

Brussels, Belgium

CHU Sart-Tilman

🇧🇪

Liege, Belgium

Centre Hospitalier de Lorraine

🇧🇪

Virton, Belgium

VZW Monica Campus Eewnfeestkliniek

🇧🇪

Antwerpen, Belgium

© Copyright 2025. All Rights Reserved by MedPath